SCHEMBL23359653

SCHEMBL23359653

CCOc1ccc(NC2CCN(C(=O)OC(C)(C)C)CC2)c2cccnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.54
NOS2 P35228 2/20 0.48
ALDH1A1 P00352 3/20 0.46
GPR119 Q8TDV5 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
DTYMK P23919 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.44
JAK1 P23458 1/20 0.43
NOS1 P29475 1/20 0.43
CCR8 P51685 1/20 0.43
USP30 Q70CQ3 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862672 0.94 EPHX2 (0.51) EPHX2NOS2USP30
SCHEMBL28834100 0.94 EPHX2 (0.51) EPHX2NOS2USP30
SCHEMBL28834101 0.94 EPHX2 (0.51) EPHX2NOS2USP30
SCHEMBL23360351 0.89 PRMT5 (0.51) EPHX2ALDH1A1GPR119L3MBTL1MAPT
SCHEMBL23360388 0.88 EPHX2 (0.49) EPHX2ALDH1A1GPR119L3MBTL1NPC1
SCHEMBL23359862 0.86 ALDH1A1 (0.49) EPHX2NOS2ALDH1A1GPR119L3MBTL1
SCHEMBL23359875 0.85 GPR119 (0.51) EPHX2NOS2ALDH1A1GPR119L3MBTL1
SCHEMBL28834157 0.85 USP30 (0.49) EPHX2ALDH1A1MAPK1USP30GAA
SCHEMBL29863210 0.85 USP30 (0.49) EPHX2ALDH1A1MAPK1USP30GAA
SCHEMBL28834238 0.85 USP30 (0.49) EPHX2ALDH1A1MAPK1USP30GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
CN-114867719-B Pyrrolidine and piperidine compounds 柳韩洋行 2024-06-25 CN disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL EPHX2 2516/4885NOS2 1575/4885ALDH1A1 439/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL EPHX2 2516/4885NOS2 1575/4885ALDH1A1 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.